Stocks in Focus: Actavis Inc, Avanir Pharmaceuticals, Catalyst Pharmaceutical Partners, Galectin Therapeutics Inc

Lakeway, TX -- (SBWIRE) -- 03/13/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Actavis Inc(NYSE:ACT) added 2.15% and is trading at $90.27. Actavis Inc., formerly Watson Pharmaceuticals, Inc., is an integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic and brand pharmaceutical products. The Company operates in three segments: Global Generics, Global Brands and Distribution.

How Should Investors Trade ACT After The Solid Jump? Let’s Find Out Here

Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX) is higher 3.80% and is trading at $0.544. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.

Is CPRX Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here

Avanir Pharmaceuticals, Inc.(NASDAQ:AVNR) moved down 2.81% and is trading at $2.94. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders.

Is AVNR Buy After The Recent Price Movement? Find Out Here

Galectin Therapeutics Inc.(NASDAQ:GALT) is higher 0.71% and is trading at $4.24.

Is GALT Buy After The Recent Price Movement? Find Out Here

About vbtrendreport.com
vbtrendreport.com’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by vbtrendreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vbtrendreport.com does expect that investors will buy and sell securities based on information assembled and presented in vbtrendreport.com. PLEASE always do your own due diligence, and consult your financial advisor.